Morgan Stanley: HTC to snap out of its 2012 hangover in Q4, buoyed by the Droid DNA and China
Hot on the heels of the encouraging November report by HTC, which saw the revenue jump more than 20% month-on-month, now comes the Morgan Stanley analysis that Q4 as a whole is looking decent for the embattled Taiwanese phone maker, too.
The investment bank analysts estimate that HTC is on track to hit its sales target numbers of 8 million handsets sold, buoyed by the introduction of the Droid DNA/Butterfly 5" Full HD handset, which is found to be as popular as you'd expect with the first brand-name phone carrying a 440ppi density screen.
The brand's HTC 8X Windows Phone is also selling in fine numbers, the shop concludes, as well as its mid-range offerings for China: "It’s early to conclude that HTC can return to its peak, but good feedback on new devices, U.S. smartphone demand re-acceleration from the fourth quarter, and an expanding premium Chinese market bode well for its share trend and operating leverage."
The revenue target for HTC in Q4 is set at $2.06 billion, and if the company is slowly coming out of its repressed state in 2012, the next year should be also good for its share price.